ESC Premium Access

Apabetalone (RVX-208) inhibits key drivers of vascular inflammation, calcification, and plaque vulnerability through a BET-dependent epigenetic mechanism

Presentation

About the speaker

Doctor Ewelina Kulikowski

Resverlogix Corp., Calgary (Canada)
1 presentation
0 follower

10 more presentations in this session

Inflammation implicated in the aetiology of major vascular and non-vascular diseases in East Asians

Speaker: Doctor M. Karim (Oxford, GB)

Thumbnail

Proprotein convertase subtilisin/kexin 9 (PCSK9) and lipopolysaccharide (LPS) in patients with atrial fibrillation. A biomarker post-hoc analysis from the ATHERO-AF cohort.

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Thumbnail

Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Speaker: Doctor D. Takagi (Kyouto, JP)

Thumbnail

Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients

Speaker: Doctor H. Yamamoto (Kobe, JP)

Thumbnail

High plasma sRAGE is associated with slower carotid intima media thickness progression and lower risk for first-time coronary events and mortality

Speaker: Mrs H. Grauen Larsen (Malmo, SE)

Thumbnail

Access the full session

Poster Session 6 - Coronary artery disease inflammation

Speakers: Doctor E. Kulikowski, Doctor M. Karim, Professor P. Pignatelli Spinazzola, Doctor D. Takagi, Doctor H. Yamamoto...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk